Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 158.65
-4.20 (-2.58%)
Sep 4, 2026, 5:31 PM CET
Galderma Group AG Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Galderma Group AG stock has a consensus rating of "Buy" and an average price target of CHF 192.06. The average 1-year stock price forecast is 21.06% higher than the current stock price, while the lowest is CHF 128.48 (-19.02%) and the highest is CHF 259.78 (+63.74%).
Price Target: CHF 192.06 (+21.06%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 29, 2026.
Analyst Ratings
The average analyst rating for Galderma Group AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 3 | 3 | 3 | 3 | 4 | 3 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 18 | 18 | 18 | 18 | 18 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Harry Sephton RBC Capital No rating | RBC Capital | Hold Maintains CHF 175.00 | Hold | Maintains | CHF 175.00 | +10.31% | Jul 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains CHF 200.00 → CHF 203.00 | Buy | Maintains | CHF 200.00 → CHF 203.00 | +27.95% | Jul 24, 2026 |
| UBS | UBS | Buy Maintains CHF 200.00 | Buy | Maintains | CHF 200.00 | +26.06% | Jul 24, 2026 |
| Barclays | Barclays | Buy Reiterates CHF 200.00 → CHF 210.00 | Buy | Reiterates | CHF 200.00 → CHF 210.00 | +32.37% | Jul 24, 2026 |
| Jefferies | Jefferies | Buy Maintains CHF 205.00 | Buy | Maintains | CHF 205.00 | +29.22% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
6.40B
from 5.24B
Increased by 22.13%
Revenue Next Year
7.45B
from 6.40B
Increased by 16.37%
EPS This Year
4.77
from 3.69
Increased by 29.24%
EPS Next Year
6.46
from 4.77
Increased by 35.49%
EPS and Forward PE are based on non-GAAP adjusted numbers.